<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muhammad Chairul</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effectiveness of Radish (Raphanus sativus) Extract In Reducing Tnf-α and Nitrit Oxida levels in Tipe II DM Mice Models with Traumatic Brain Injury</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Nitric oxide</style></keyword><keyword><style  face="normal" font="default" size="100%">Raphanus sativus</style></keyword><keyword><style  face="normal" font="default" size="100%">TNF-α</style></keyword><keyword><style  face="normal" font="default" size="100%">Traumatic Brain Injury</style></keyword><keyword><style  face="normal" font="default" size="100%">Wistar rats.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">597-601</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The devastating effects of traumatic brain injury (TBI) are fatal, and there is no effective treatment for primary brain injury, especially in patients with diabetes mellitus (DM). Nitric oxide (NO) is a compound that causes systemic vasodilation; a decrease in NO reduces cerebral blood flow after TBI. There is an increase in TNF-α levels demonstrated by mononuclear cells surrounding the traumatic lesion in the rat brain. &lt;em&gt;Raphanus sativus &lt;/em&gt;(radish) is a root vegetable belonging to the Brassicaceae family, which has anti-diabetic effects by lowering blood glucose levels, reducing lipid peroxidation, and improving brain function, thereby protecting against neurotoxic effects associated with oxidative stress in experimental mouse models. &lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the efficacy of radish extract &lt;em&gt;(Raphanus sativus)&lt;/em&gt; in reducing TNF-α and nitric oxide levels in a rat model of type II diabetes mellitus with traumatic brain injury. Method: This study was an in vivo laboratory experimental study with a post-test only control group design. The study population consisted of 25 Wistar rats, which were then induced with diabetes and subjected to a modified Feeney Model closed head injury. After complete data collection, KGD and ELISA assessments were performed, followed by data analysis. &lt;strong&gt;Results: &lt;/strong&gt;There were significant differences (p&amp;lt;0.05) in serum NO and serum TNF-α levels between the normal group, the 100 mg/kg radish extract group, the 300 mg/kg radish extract group, and the 500 mg/kg radish extract group compared to the negative control group. This indicates that radish extract, starting at a dose of 100 mg/kg, can reduce serum NO and serum TNF-α levels. &lt;strong&gt;Conclusion: &lt;/strong&gt;Radish extract &lt;em&gt;(Raphanus sativus)&lt;/em&gt; is effective in reducing TNF-α and nitric oxide levels in a Wistar rat model of type II DM with traumatic brain injury.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">597</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Muhammad Chairul&lt;sup&gt;1*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Medical Science Faculty of Medicine, Dentistry, and Health Sciences, Universitas Prima Indonesia, Medan, INDONESIA&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Khadijatul Fatiyah Mubarak</style></author><author><style face="normal" font="default" size="100%">Amran Razak</style></author><author><style face="normal" font="default" size="100%">Muhammad Alwy Arifin</style></author><author><style face="normal" font="default" size="100%">Balqis</style></author><author><style face="normal" font="default" size="100%">Muhammad Kardi</style></author><author><style face="normal" font="default" size="100%">Hasnawati Amqam</style></author><author><style face="normal" font="default" size="100%">Anwar Mallongi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Analysis of Implementation of the Prolanis-Diabetes Mellitus Chronic Disease Management Program in Majene Regency</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">BPJS Health and bureaucracy</style></keyword><keyword><style  face="normal" font="default" size="100%">Cronis Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Prolanis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">644-649</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;In the context of health maintenance for BPJS health participants who suffer from chronic diseases, PROLANIS is a proactive strategy and health care system that is implemented in an integrated way involving participants, health facilities, and BPJS health. In this work, a case study methodology is combined with a qualitative method. Content analysis was employed to analyze the data. Thirteen informants—four key informants and nine routine informants—were interviewed. The research on the communication between program implementers yielded positive results, the BPJS budget was allocated effectively, and the human resource numbers of the various health centers varied, but the facilities and infrastructure were more than sufficient, and the implementation skills were strong. Proceeding by current SOPs, the bureaucracy still needs improvement and regulation, and the BPJS incentives both reward and efficiently distribute money. Conclusion: Both Community Health Centers acknowledge that funding from BPJS is fairly good. Notifications and reminders of activities have been successfully implemented in the Diabetes Mellitus Chronic Disease Management Program (PROLANIS) policy, even though only those who are active and present are the same. Infrastructure and facilities are sufficient; however, there is room for improvement in the amount, quality, and integrity of human resources. Additionally, the appointment of bureaucracy requires attention, and it may be more effectively divided.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">644</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Khadijatul Fatiyah Mubarak&lt;sup&gt;1&lt;/sup&gt;*, Amran Razak&lt;sup&gt;2&lt;/sup&gt;, Muhammad Alwy Arifin&lt;sup&gt;3&lt;/sup&gt;, Balqis&lt;sup&gt;4&lt;/sup&gt;, Muhammad Kardi&lt;sup&gt;4&lt;/sup&gt;, Hasnawati Amqam&lt;sup&gt;4&lt;/sup&gt;, Anwar Mallongi&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Postgraduate Student Department of Health Administration and Policy, Faculty of Public Health Hasanuddin University, Makassar, South Sulawesi, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Health Administration and Policy, Faculty of Public Health Hasanuddin University, Makassar, South Sulawesi, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Chairman of Health Administration and Policy, Faculty of Public Health Hasanuddin University, Makassar, South Sulawesi, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Head of the Study Program Bachelor of Public Health Faculty of Public Health Hasanuddin University Maka&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Suci Fajriani S</style></author><author><style face="normal" font="default" size="100%">Amran Razak</style></author><author><style face="normal" font="default" size="100%">Muhammad Alwy Arifin</style></author><author><style face="normal" font="default" size="100%">Muhammad Yusran Amir</style></author><author><style face="normal" font="default" size="100%">Anwar Mallongi</style></author><author><style face="normal" font="default" size="100%">Muhammad Syafar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Analysis of the Implementation of the Bpjs Kesehatan Chronic Diseases Management Program (Prolanis) in Biru Health Center, Bone Regency</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">BPJS Kesehatan.</style></keyword><keyword><style  face="normal" font="default" size="100%">Chronic Disease Management Program (Prolanis)</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Health Center</style></keyword><keyword><style  face="normal" font="default" size="100%">Hypertension</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">872-879</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objectives:&lt;/strong&gt; Prolanis is a health service system that involves patients, primary health facilities and BPJS. Prolanis aims to maintain health and achieve an optimal quality of life in patients with chronic disease (hypertension and diabetes mellitus) through effective and efficient health services to prevent disease complications. This study aims to determine and analyze the implementation of Prolanis in the Biru Health Center of Bone Regency based on input, process, output, impact, and feedback. &lt;strong&gt;Method:&lt;/strong&gt; The type of research used in this research is qualitative research, and data were collected through technical triangulation using in-depth interviews, observation, and documentation with key informants, main informants and supporting informants using purposive sampling techniques. &lt;strong&gt;Result:&lt;/strong&gt; Research shows that in the input aspect, blood sugar strips used in health checks of prolanist participants are still limited, and there are no special facilities for prolanis. In terms of process, Biru Health Center has carried out all prolanist activities recommended by BPJS Kesehatan. However, some obstacles remain to these activities, such as prolanist participants who do not have Whats App, and laboratory HbA1c examinations every six months have not been carried out. In the output aspect, the achievement of the Biru Health Center RPPT has increased significantly from October 2023 to January 2024, although it decreased in November 2023. Regarding impact, BPJS Kesehatan, the Health Office, and Prolanis Participants are satisfied with implementing the prolanis at the Biru Health Center. Feedback from BPJS Kesehatan is available through the KBK monitoring and evaluation. &lt;strong&gt;Conclusion&lt;/strong&gt;: Implementing prolanists at Biru Health Center has gone well and as expected. However, the input aspect still needs to be improved so that the implementation of prolanists can run even better.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">872</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Suci Fajriani S&lt;sup&gt;1*&lt;/sup&gt;, Amran Razak&lt;sup&gt;2&lt;/sup&gt;, Muhammad Alwy Arifin&lt;sup&gt;2&lt;/sup&gt;, Muhammad Yusran Amir&lt;sup&gt;2&lt;/sup&gt;, Anwar Mallongi&lt;sup&gt;3&lt;/sup&gt;, Muhammad Syafar&lt;sup&gt;4&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Masters Student of Health Administration and Policy, Faculty of Public Health, Hasanuddin University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Health Administration and Policy, Faculty of Public Health,&amp;nbsp;Hasanuddin University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Environmental Health, Faculty of Public Health,&amp;nbsp;Hasanuddin University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Health Promotion and Behavioral Sciences, Faculty of Public Health,&amp;nbsp;Hasanuddin University, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Octarina Ervianti</style></author><author><style face="normal" font="default" size="100%">Wimbo Sasono</style></author><author><style face="normal" font="default" size="100%">Reni Prastyani</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Effects of Melon Superoxide Dismutase and Gliadin on Glutathione Reductase (GSH) and Superoxide Dismutase (SOD) Levels in Blood Plasma and Vitreoretina in Diabetic Rat Model: A Literature Review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Blood Plasma</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Glisodin®</style></keyword><keyword><style  face="normal" font="default" size="100%">GSH</style></keyword><keyword><style  face="normal" font="default" size="100%">SOD</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitreoretina</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1202-1208</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Chronic hyperglycemia in diabetics causes microvascular damage through four mechanisms of biochemical changes, including activated protein kinase C (PKC) pathway, activated hexosamine pathway, increased polyol pathway, and increased advanced glycation end-products (AGEs), all of which will increase Reactive Oxygen Species (ROS) levels. ROS can damage proteins, nucleic acids, and lipids and hasten the onset of diabetes. ROS are produced in the presence of normal blood sugar levels, and the natural breakdown of glucose is controlled by insulin. Variables that regulate cellular respiration, including NAD-related substrates, oxygen, succinate, and antioxidant enzymes, modulate ROS levels and sustain cellular redox equilibrium. The conversion of superoxide anions into hydrogen peroxide, before subsequently metabolized into water by catalase and glutathione (GSH) peroxidase, is facilitated by the metalloprotein superoxide dismutase (SOD). Increased ROS levels can lead to diabetic complications, one of which is diabetic retinopathy. Melon superoxide dismutase (SOD) combined with gliadin (Glisodin&lt;sup&gt;®&lt;/sup&gt;) is a potent antioxidant in counteracting free radicals that can reduce oxidative stress and prevent further cell death. Research related to the use of Glisodin&lt;sup&gt;® &lt;/sup&gt;shows potential as an antioxidant agent with the hope of preventing diabetic complications.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">1202</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Octarina Ervianti, Wimbo Sasono*, Reni Prastyani&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Ophthalmology, Dr. Soetomo General Academic Hospital / Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tini</style></author><author><style face="normal" font="default" size="100%">Darmawansyah</style></author><author><style face="normal" font="default" size="100%">Ridwan Amiruddin</style></author><author><style face="normal" font="default" size="100%">Masni</style></author><author><style face="normal" font="default" size="100%">Anwar Mallongi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Identification of Effort and Issues in the Prevention of Diabetic Foot in the Community: A Qualitative Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetic foot prevention.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">895-901</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Diabetic foot is one of chronic complications that can cause significant issue on diabetes mellitus patient. In addition to contributing to mortality and morbidity rate, this disease also increases the family as well as national health economy burdens. Therefore, preventive efforts are necessary to decrease the risk of diabetic foot. In this case, intervention model in preventing diabetic foot is known to focus more on diabetes mellitus patients and healthcare service provider. Objective: Current research aims to identify the determinant of the efforts and issues in the prevention of diabetic foot in the community. &lt;strong&gt;Method:&lt;/strong&gt; This research applied qualitative method through focus group discussion and indepth interview with 19 informants selected through purposive sampling, including the holder of Public Health Center programs, cadre, diabetes mellitus patients, and family. Data obtained through record were further transcribed and analyzed thematically. &lt;strong&gt;Result:&lt;/strong&gt; There are several themes produced, including the education of foot care, cadre empowerment, role of cadre, strategy of cadre empowerment, knowledge, perception, self-efficacy, as well as patient and family strengthening. &lt;strong&gt;Conclusion:&lt;/strong&gt; Diabetic foot preventive efforts focuses on the education of foot care and cadre empowerment in the community. Meanwhile, the issues discovered include the lack of knowledge, perception, efficacy and behavior in taking care of foot on diabetes mellitus patients. Hence, further study is needed in designing proper intervention strategy to prevent diabetic foot in the community.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">895</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Tini&lt;sup&gt;1,2*&lt;/sup&gt;, Darmawansyah&lt;sup&gt;1&lt;/sup&gt;, Ridwan Amiruddin&lt;sup&gt;1&lt;/sup&gt;, Masni&lt;sup&gt;1&lt;/sup&gt;, Anwar Mallongi&lt;sup&gt;1&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Public Health, Universitas Hasanuddin, Makassar, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Nursing Department,&amp;nbsp;Poltekkes Kemenkes of East Kalimantan, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mohamed Zaeim Hafez Ahmed</style></author><author><style face="normal" font="default" size="100%">Muhammad Abdelbaeth Hassan Elfiky</style></author><author><style face="normal" font="default" size="100%">Elsayed Elagamy Elsayed Mohamed</style></author><author><style face="normal" font="default" size="100%">Ramadan Hassan Ibrahim Thabet</style></author><author><style face="normal" font="default" size="100%">Ahmed Mohamed Gad Allah</style></author><author><style face="normal" font="default" size="100%">Ahmed Abdrabo Elshenawy Elsisi</style></author><author><style face="normal" font="default" size="100%">Ahmed Abdel Nasser Ahmed Mohamed</style></author><author><style face="normal" font="default" size="100%">Tarek Shikhon</style></author><author><style face="normal" font="default" size="100%">Mostafa Abo-akrab</style></author><author><style face="normal" font="default" size="100%">Sayed A.M.Mahmoud</style></author><author><style face="normal" font="default" size="100%">Mohamed AbdelAziz Doma</style></author><author><style face="normal" font="default" size="100%">Wael Ahmed Mahmoud Khattab</style></author><author><style face="normal" font="default" size="100%">Khaled Saleh Ali Elhamaky</style></author><author><style face="normal" font="default" size="100%">Mohamed El- Salamoni</style></author><author><style face="normal" font="default" size="100%">Fatma Mahmoud Abdelraheem</style></author><author><style face="normal" font="default" size="100%">Mahmoud Ahmad Mohamed Azab</style></author><author><style face="normal" font="default" size="100%">Mahmoud Ahmad Mohamed Azab6</style></author><author><style face="normal" font="default" size="100%">Mohamed E EL-Refaey</style></author><author><style face="normal" font="default" size="100%">Ahmed A. Abd El-Rhman</style></author><author><style face="normal" font="default" size="100%">Ahmed F. Abdel Ghany</style></author><author><style face="normal" font="default" size="100%">Ghada Adel Hegazy</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Influence of Chamomile Leaves extract in Different Doses on Renal Functions and Diabetic indices in Streptozotocin – Induced Diabetic Rat</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Chamomile leaves</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Streptozotocin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1029-1035</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; The prevalence of diabetes among Egyptians is rising. Therefore, there is always a demand for innovative natural medicines. Medicinal plants have long been a significant source in search of novel, effective alternatives for human therapy. Chamomile is one of the most widely used medicinal plants, which may help hyperglycemic patients by lowering blood sugar levels. Objectives: To determine how chamomile extract affects the kidneys when albino male rats with chronic diabetes are induced by streptozotocin (STZ). &lt;strong&gt;Methods:&lt;/strong&gt; The study was conducted in the Al-Azhar Faculty of Medicine (Assiut) pharmacology department animal laboratory. For this investigation, a local strain of fifty adult male albino rats was used as the animal model and weighed 120 to 150 g. In this study, rats were divided into five groups, body weight, and systolic blood pressure was measured, and blood samples were collected for measuring blood glucose and insulin level, HbA1c, Na, K, and renal function tests, and histopathological examination was done. &lt;strong&gt;Results:&lt;/strong&gt; After the study, mean glucose levels, HbA1c, urea, creatinine, K, and systolic blood pressure were significantly decreased in group IV &amp;amp; group V compared to group III. In contrast, body weight serum insulin level and Na increased dramatically in group IV &amp;amp; group V compared to group III.&lt;strong&gt; Conclusion:&lt;/strong&gt; The serum levels of urea and creatinine in diabetic patients may be positively affected by chamomile. Additionally, short-term chamomile uses benefits diabetic individuals by decreasing loss of body weight, lowering HbA1c, and increasing insulin levels.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1029</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Mohamed Zaeim Hafez Ahmed&lt;sup&gt;1*&lt;/sup&gt;, Muhammad Abdelbaeth Hassan Elfiky&lt;sup&gt;1&lt;/sup&gt;, Elsayed Elagamy Elsayed Mohamed&lt;sup&gt;2&lt;/sup&gt;, Ramadan Hassan Ibrahim Thabet&lt;sup&gt;2&lt;/sup&gt;, Ahmed Mohamed Gad Allah&lt;sup&gt;3&lt;/sup&gt;, Ahmed Abdrabo Elshenawy Elsisi&lt;sup&gt;2&lt;/sup&gt;, Ahmed Abdel Nasser Ahmed Mohamed&lt;sup&gt;2&lt;/sup&gt;, Tarek Shikhon&lt;sup&gt;4&lt;/sup&gt;, Mostafa Abo-akrab4, Sayed A.M.Mahmoud&lt;sup&gt;5&lt;/sup&gt;, Mohamed AbdelAziz Doma&lt;sup&gt;5&lt;/sup&gt;, Wael Ahmed Mahmoud Khattab&lt;sup&gt;6&lt;/sup&gt;, Khaled Saleh Ali Elhamaky&lt;sup&gt;7&lt;/sup&gt;, Mohamed El-Salamoni&lt;sup&gt;6&lt;/sup&gt;, Fatma Mahmoud Abdelraheem&lt;sup&gt;8,&lt;/sup&gt; Mahmoud Ahmad Mohamed Azab&lt;sup&gt;6&lt;/sup&gt;, Ashraf Abdel Aty Elshenawy Emara&lt;sup&gt;6&lt;/sup&gt;, Mohamed E EL-Refaey&lt;sup&gt;1&lt;/sup&gt;, Ahmed A. Abd El-Rhman&lt;sup&gt;1&lt;/sup&gt;, Ahmed F. Abdel Ghany&lt;sup&gt;1&lt;/sup&gt;, Ghada Adel&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Faculty of Medicine, Al-Azhar University (Assiut), Assiut, EGYPT.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ruqiah Ganda Putri Panjaitan</style></author><author><style face="normal" font="default" size="100%">Titin</style></author><author><style face="normal" font="default" size="100%">Yohanes Gatot Sutapa Yuliana</style></author><author><style face="normal" font="default" size="100%">Siti Khotimah</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Plants with Antidiabetic Efficacy among the Dayak Bidayuh Community, Sanggau Regency, West Kalimantan, Indonesia</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Dayak Bidayuh Tribe</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicinal plants</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1342-1348</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; The use of medicinal plants for diabetes mellitus has been practiced for generations by the Dayak communities in West Kalimantan, Indonesia. The aim of this study is to inventory and describe the utilization of medicinal plants for diabetes mellitus by the Dayak Bidayuh Kerambay, Dayak Golik, and Dayak Sinangkan’t communities in Sekayam, Beduai, and Entikong Districts, Sanggau Regency, West Kalimantan, Indonesia. &lt;strong&gt;Method:&lt;/strong&gt; This research is a qualitative descriptive study using triangulation method combining interview, observation, and documentation techniques of anti-diabetic mellitus medicinal plants among the Dayak communities. &lt;strong&gt;Results: &lt;/strong&gt;The plants used as anti-diabetic mellitus include Physalis angulata L.,&lt;em&gt; Ageratum&lt;/em&gt; &lt;em&gt;conyzoides &lt;/em&gt;L., &lt;em&gt;Piper betle&lt;/em&gt; L.,&lt;em&gt; Dillenia suffruticosa&lt;/em&gt; (Griff.) Martelli, &lt;em&gt;Syzygium polyanthum&lt;/em&gt; (Wight) Walp. &lt;em&gt;Stenochlaena palustris&lt;/em&gt; (Burm.f.) Bedd, &lt;em&gt;Gynura procumbens&lt;/em&gt; (Lour.) Merr, &lt;em&gt;Curcuma domestica Valeton&lt;/em&gt;,&lt;em&gt; Zingiber officinale Rosc&lt;/em&gt;., &lt;em&gt;Eleutherine palmifolia&lt;/em&gt; (L.) Merr, &lt;em&gt;Curcuma zedoaria&lt;/em&gt; (Christm.) Roscoe, &lt;em&gt;Orthosiphon stamineus&lt;/em&gt; B., &lt;em&gt;Nepenthes&lt;/em&gt; sp., &lt;em&gt;Solanum torvum&lt;/em&gt; Swartz, &lt;em&gt;Garcinia mangostana &lt;/em&gt;L. The plant parts most commonly used, in sequence, are leaves, rhizomes, roots, fruits, fruit peels, and sometimes the entire plant. The method of preparation for each type of plant is the same, which involves boiling and consuming the boiled decoction. &lt;strong&gt;Summary: &lt;/strong&gt;There are 15 types of plants used by the Dayak tribe community to address diabetes mellitus. Among these 15 types of plants, different parts are utilized, while the processing method remains the same, which is boiling.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1342</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ruqiah Ganda Putri Panjaitan&lt;sup&gt;1*&lt;/sup&gt;, Titin&lt;sup&gt;1&lt;/sup&gt;, Yohanes Gatot Sutapa Yuliana&lt;sup&gt;2&lt;/sup&gt;, Siti Khotimah&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Biology Education Program, Faculty of Teacher Training and Education, Tanjungpura University, Prof. Dr. H. Hadari Nawawi Street, Bansir Laut, Southeast Pontianak District, Pontianak City, West Kalimantan 78124, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;English Language Education Program, Faculty of Teacher Training and Education, Tanjungpura University, Prof. Dr. H. Hadari Nawawi Street, Bansir Laut, Southeast Pontianak District, Pontianak City, West Kalimantan 78124, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Biology Study Program, Faculty of Mathematics and Natural Sciences, Tanjungpura University, Prof. Dr. H. Hadari Nawawi Street, Bansir Laut, Southeast Pontianak District, Pontianak City, West Kalimantan 78124, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aditya Chrisdianto</style></author><author><style face="normal" font="default" size="100%">Prananda Surya Airlangga</style></author><author><style face="normal" font="default" size="100%">Belindo Wirabuana</style></author><author><style face="normal" font="default" size="100%">Regina Purnama Dewi Iskandar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vitamin D and Wound Recovery: Illuminating the Path to Enhanced Healing in Diabetic Patients</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Macrophage Polarisation</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitamin D</style></keyword><keyword><style  face="normal" font="default" size="100%">Wound Healing</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">485-491</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Wound healing is a highly coordinated biological event as a response to injured skin. It commonly takes 14 days for a wound to be completely healed. However, the duration of wound healing may vary between individuals due to certain factors. One major factor that delays the wound-healing process is Diabetes Mellitus. Delayed wound healing with poor prognosis commonly occurs in diabetic patients. Chronic hyperglycemia may affect macrophage polarisation, which is essential in the wound healing mechanism. The macrophage polarisation enables the pro-inflammatory M1 phenotype to switch to the anti-inflammatory M2 phenotype. Thus, pro-inflammatory M1 phenotype prevails persistently in diabetic wounds, while the anti-inflammatory M2 phenotype remains deficient. It results in significantly elevated levels of pro-inflammatory cytokines triggered by the M1 phenotype. Prolonged wound healing times increase the risk of infection, which can lead to more severe complications. Vitamin D is widely recognized for its essential role in regulating calcium levels and supporting bone health, as well as its positive effects on the immune system. This vitamin has the potential to skew macrophages towards the M2 phenotype and promote a regenerative and anti-inflammatory environment.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">485</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Aditya Chrisdianto&lt;sup&gt;1&lt;/sup&gt;, Prananda Surya Airlangga&lt;sup&gt;2*&lt;/sup&gt;, Belindo Wirabuana&lt;sup&gt;2&lt;/sup&gt;, Regina Purnama Dewi Iskandar&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Master Program of Clinical Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Anaesthesiology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA. 3Department of Orthodontics, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nolitha Nkobole</style></author><author><style face="normal" font="default" size="100%">Lavhelesani R. Managa</style></author><author><style face="normal" font="default" size="100%">Gerhard Prinsloo</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antidiabetic and Hypoglycaemic Activities of Commonly Used African Traditional Vegetables</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">African traditional vegetables</style></keyword><keyword><style  face="normal" font="default" size="100%">Antidiabetic</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Hypoglycaemic</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemicals.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">339-356</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Diabetes mellitus is a common and complex metabolic disorder associated with high blood glucose levels leading to complications. Adopting a sedentary lifestyle characterized by low physical activity and consumption of high-energy diets contributes to the development of diabetes mellitus. Lifestyle changes and the use of pharmacological agents that target particular biochemical pathways involved in nutrient metabolism are currently used as management guidelines for managing risk factors associated with diabetes mellitus. The use of prescription medications for an extended period is linked to several negative side effects. Alternative management strategies of risk factors linked to diabetes mellitus involve the use of African leafy vegetables. African leafy vegetables contain a variety of biologically active compounds that provide health benefits. These crops have the potential to be a valuable source of new oral hypoglycemic agents for diabetes management. This review analyses the antidiabetic activities of nine African leafy vegetables whilst also defining the gap areas for future research. &lt;strong&gt;Methods&lt;/strong&gt;: Data was acquired via electronic search engines of which only peer-reviewed papers published in journals were considered. &lt;strong&gt;Results: &lt;/strong&gt;African traditional vegetables showed diverse&lt;em&gt; in vitro &lt;/em&gt;and&lt;em&gt; in vivo&lt;/em&gt; antidiabetic activities. &lt;strong&gt;Conclusions:&lt;/strong&gt; There is an urgent need to document and use the knowledge of African leafy vegetables that have potential in the treatment and management of diabetes mellitus.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">339</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Nolitha Nkobole&lt;sup&gt;1,*&lt;/sup&gt;, Lavhelesani R. Managa&lt;sup&gt;2&lt;/sup&gt;, Gerhard Prinsloo&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Agriculture and Animal Health, University of South Africa, Science campus, Florida, SOUTH AFRICA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Africa Institute of South Africa, Human Sciences Research Council, Pretoria, SOUTH AFRICA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tini</style></author><author><style face="normal" font="default" size="100%">Darmawansyah</style></author><author><style face="normal" font="default" size="100%">Ridwan Amiruddin</style></author><author><style face="normal" font="default" size="100%">Masni</style></author><author><style face="normal" font="default" size="100%">Anwar Mallongi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cadre Interventions on Health Outcomes of Diabetes Mellitus Patients: Systematic Review of Randomized Control Trial</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cadres</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Health outcomes.</style></keyword><keyword><style  face="normal" font="default" size="100%">Intervention</style></keyword><keyword><style  face="normal" font="default" size="100%">Roles</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">697-702</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Diabetes mellitus is a disease that can cause complications in various organs of the body. There needs to be a strategic effort to improve the health outcomes of diabetes mellitus patients. Research studies show that cadres are able to become liaisons between patients and health care providers and make a positive contribution to the surrounding community. This systematic study aimed to review studies on cadre interventions on health outcomes of diabetes mellitus patients. &lt;strong&gt;Methods:&lt;/strong&gt; The literature search was carried out on the online databases of PubMed, Proquest, and Google Scholar journals published in the range of 2015 – 2021. The keywords used included community health worker, intervention, health outcomes, and diabetes mellitus. Meanwhile, the literature criteria used included journal articles, peer-reviewed, written in English, and research studies with the Randomized Control Trial (RCT) design. &lt;strong&gt;Result: &lt;/strong&gt;Based on the results of a review of 15 selected articles, it was found that the overall interventions carried out were providing education, counseling, and group classes. Other activities include home visits, goal setting and action plans, diabetes mellitus diaries, and follow-up phone calls. There were interventions carried out by cadres, in partnership with health care providers and academic partners, involving peers of diabetes mellitus patients and culturally relevant community resources. &lt;strong&gt;Conclusion&lt;/strong&gt;: The results of the review showed that almost all articles found changes in metabolic control, behavior, and psychosocial of diabetes mellitus patients as a result of the interventions. Therefore, there needs to conduct subsequent studies on the effect of cadre interventions on the prevention of disease complications both macrovascular and microvascular.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">697</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Tini&lt;sup&gt;1,2,*&lt;/sup&gt;, Darmawansyah&lt;sup&gt;1&lt;/sup&gt;, Ridwan Amiruddin&lt;sup&gt;1&lt;/sup&gt;, Masni&lt;sup&gt;1&lt;/sup&gt;, Anwar Mallongi&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Public Health, Universitas Hasanuddin, Makassar, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Nursing Department, Poltekkes Kemenkes of East Kalimantan, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jimenez-Arellanes Maria Adelina</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Clinical Studies of Silymarin as a Protective Agent Against Liver Damage Caused by Anti-TB Drugs, Methotrexate, and in Cases of Chronic Hepatitis C and Diabetes Mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-TB drugs</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatoprotector</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Methotrexate</style></keyword><keyword><style  face="normal" font="default" size="100%">Nephroprotector</style></keyword><keyword><style  face="normal" font="default" size="100%">Silybin</style></keyword><keyword><style  face="normal" font="default" size="100%">Silymarin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">358-368</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The liver is the organ in charge of homeostasis and metabolism of sundry substances (endogenous and exogenous, including drugs); but when these are metabolized, they generate more toxic and/or reactive metabolites, that can damage the liver causing cirrhosis, steatosis and/or hepatocarcinoma. Human have been used several medicinal plants (MP) since ancestral times to treat their ailments, diseases and liver disorders, including&lt;em&gt; Sylibum marianum&lt;/em&gt;. This MP is used in the treatment of jaundice and other biliary diseases, as well as in support therapy for edible mushrooms poisoning and in the treatment of some hepatic diseases. From this medicinal plant, silymarin (SLM, mixture of flavonoids) is obtained, it has an important antioxidant, anti-inflammatory and hepatoprotector effect. The last activity has been demonstrated through several preclinical and in some clinical studies. To date, a few clinical studies describe the hepatoprotective and/or nephroprotective effect of SLM against the damage caused by anti- TB drugs, methotrexate and in cases of type II diabetes mellitus or chronic hepatitis C. Nevertheless, this type of research is more frequent in preclinical trials (using rats or mice) or in vitro assay.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article </style></work-type><section><style face="normal" font="default" size="100%">358</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Jimenez-Arellanes Maria Adelina&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Unidad de Investigación Médica en Farmacología, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Av. Cuauhtémoc 330, Col. Doctores, Delg, Cuauhtémoc 06720, CDMX, MEXICO.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Omar Khaled Al-Mobideen</style></author><author><style face="normal" font="default" size="100%">Ali Abdallah Alqudah</style></author><author><style face="normal" font="default" size="100%">Ahmed Al-Mustafa</style></author><author><style face="normal" font="default" size="100%">Fuad Alhawarat</style></author><author><style face="normal" font="default" size="100%">Hussam Mizher</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Crataegus aronia on the Biochemical Parameters in Induced Diabetic Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antioxidant</style></keyword><keyword><style  face="normal" font="default" size="100%">Biochemical parameters</style></keyword><keyword><style  face="normal" font="default" size="100%">Crataegus aronia</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Insulin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">587-595</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;em&gt;Crataegus aronia&lt;/em&gt; is widely known for its antioxidant, anti-inflammatory, and hypolipidemic properties, and it has traditionally been used to treat cardiovascular disorders. This study aimed to evaluate the impact of &lt;em&gt;Crataegus aronia&lt;/em&gt; extract on the liver enzyme markers, blood glucose levels, lipid profiles, and kidney function biomarkers as well as hematological parameters in induced diabetic rats. Male Wistar rats were divided into seven groups: normal Control; Diabetic; and Diabetic animals treated with two doses of &lt;em&gt;Crataegus aronia&lt;/em&gt; extract (5 and 10mg/kg) (DM + extract), Control treated with the extract ( 5 and 10mg/ kg) and induced diabetic treated with insulin. Streptozotocin (STZ)-induced diabetic rats (50 mg/kg, ip)and normal were orally administrated with &lt;em&gt;Crataegus aronia&lt;/em&gt; extract once a day for 4 weeks. At the end of the experiment, the biochemical and hematological parameters were measured in all groups. Also, the phytochemicals and antioxidant activity of the &lt;em&gt;Crataegus aronia&lt;/em&gt; extract were evaluated. According to findings, the total phenols, total flavonoid, and flavonol contents were 538.3 mg Galic acid equivalent /g extract, 149.3 mg Rutin equivalent / g extract, and 79.3 mg Rutin equivalent / g extract), respectively. The antioxidant activity according to 2,2-diphenyl-2-picrylhydrazyl (DPPH) IC&lt;sub&gt;50&lt;/sub&gt; and ferric reducing antioxidant power (FRAP) assays were 28.02 μg/ml and in the range of 0.273 – 0.960 μmol Fe&lt;sup&gt;+2&lt;/sup&gt;/g dw, respectively. &lt;em&gt;Crataegus aronia &lt;/em&gt;extract significantly (p &amp;lt;0.05) affects red blood cells, hemoglobin, hematocrit, white blood cells, lymphocytes, and platelets values. Also, &lt;em&gt;Crataegus aronia&lt;/em&gt; had a significant (P &amp;lt; 0.05) effect on serum biochemical parameters, including glucose, total proteins, albumins, triglycerides, creatinine, bilirubin, and serum aspartate aminotransferase (AST). However, &lt;em&gt;Crataegus aronia&lt;/em&gt; treatment had no significant effects (p &amp;lt; 0.05) on serum alanine aminotransferase, alkaline phosphatase, and cholesterol levels.&lt;em&gt; Crataegus aronia &lt;/em&gt;exerts antioxidant activity and significantly improves the biochemical and hematological biomarkers in induced diabetic rats.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">587</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Omar Khaled Al-Mobideen&lt;sup&gt;1&lt;/sup&gt;, Ali Abdallah Alqudah&lt;sup&gt;2&lt;/sup&gt;, Ahmed Al- Mustafa&lt;sup&gt;3*&lt;/sup&gt;,Fuad Alhawarat&lt;sup&gt;1&lt;/sup&gt;, Hussam Mizher&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of paramedics, Prince Al-Hussein bin Abdullah II Academy of Civil Protection, Al- Balqa' Applied University, JORDAN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Applied Biology, Tafila Technical University, JORDAN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Biology, Mutah University, JORDAN. 4Department of Basic Medical Sciences, Kulliyyah of Pharmacy, Pahang, MALAYSIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Maulana Yusuf Alkandahri</style></author><author><style face="normal" font="default" size="100%">Dani Sujana</style></author><author><style face="normal" font="default" size="100%">Dadang Muhammad Hasyim</style></author><author><style face="normal" font="default" size="100%">Mareetha Zahra Shafirany</style></author><author><style face="normal" font="default" size="100%">Lela Sulastri</style></author><author><style face="normal" font="default" size="100%">Maya Arfania</style></author><author><style face="normal" font="default" size="100%">Dedy Frianto</style></author><author><style face="normal" font="default" size="100%">Farhamzah</style></author><author><style face="normal" font="default" size="100%">Anggun Hari Kusumawati</style></author><author><style face="normal" font="default" size="100%">Nia Yuniarsih</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antidiabetic Activity of Extract and Fractions of Castanopsis costata Leaves on Alloxan-induced Diabetic Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antidiabetic activity</style></keyword><keyword><style  face="normal" font="default" size="100%">Castanopsis costata</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">North Sumatra.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1589-1593</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;In North Sumatra, Castanopsis costata is commonly used by traditional practitioners for the treatment of diabetes mellitus, however, no studies have been carried out to substantiate this practice. Therefore, this study aims to evaluate the anti-diabetic activity of extract and fractions of C. costata leaves in mice with alloxan-induced diabetes. &lt;strong&gt;Methods:&lt;/strong&gt; Swiss albino mice with alloxan-induced diabetes, were acquired and subjected to the experimental evaluations. Subsequently, the fasting blood glucose levels of the diabetic mice groups treated with glibenclamid, extract and fractions, as well as the untreated group, were evaluated after two weeks of therapy. &lt;strong&gt;Results: &lt;/strong&gt;Based on the results, the ethanolic extract of C. costata considerably reduced the mice’s blood glucose levels in a dose-dependent manner, at dosages of 25, 50, 100, and 200 mg/kgBW (% DBGL: 21.10%, 46.36%, 58.94%, and 60.93%, respectively). In addition, the water fraction of C. costata leaves produced a greater reduction in blood glucose levels (% DBGL: 78.93%), compared to the ethyl acetate and n-hexane fractions (% DBGL: 67.06% and 58.83%), respectively. Meanwhile, treatment with the antidiabetic drug, glibenclamide (5 mg/kgBW) produced a 50.75% reduction in blood glucose levels. &lt;strong&gt;Conclusion: &lt;/strong&gt;Based on the findings, the extract and fractions of C. costata leaves were concluded to exhibit significant anti-diabetic activity. This supported the claim that traditional practitioners in North Sumatra use the plant extract for diabetes treatment.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1589</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Maulana Yusuf Alkandahri&lt;sup&gt;1&lt;/sup&gt;,&lt;sup&gt;*&lt;/sup&gt;, Dani Sujana&lt;sup&gt;2&lt;/sup&gt;, Dadang Muhammad Hasyim&lt;sup&gt;2&lt;/sup&gt;, Mareetha Zahra Shafirany&lt;sup&gt;3&lt;/sup&gt;, Lela Sulastri&lt;sup&gt;4&lt;/sup&gt;, Maya Arfania&lt;sup&gt;1&lt;/sup&gt;, Dedy Frianto&lt;sup&gt;1&lt;/sup&gt;, Farhamzah&lt;sup&gt;1&lt;/sup&gt;, Anggun Hari Kusumawati&lt;sup&gt;1&lt;/sup&gt;, Nia Yuniarsih&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy, Buana Perjuangan Karawang University, Karawang, West Java, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Diploma Program of Pharmacy, Karsa Husada Garut College of Health Sciences, Garut, West Java, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmaceutical Biology, School of Pharmacy Muhammadiyah Cirebon, Cirebon, West Java, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy Muhammadiyah Cirebon, Cirebon, West Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ruqiah Ganda Putri Panjaitan</style></author><author><style face="normal" font="default" size="100%">Agus Astuti</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antidiabetic Activity of the Leaf Extract of Eurycoma Longifolia Jack. in Streptozotocin-Nicotinamide Induced Diabetic Model</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Blood glucose level</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Eurycoma longifolia Jack. leaf.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1582-1588</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;One of the medication attempts in diabetes mellitus is by utilising plants that are potent as an antioxidant. Eurycoma longifolia Jack. known as “Longjack” in English, is a medicinal plant and reportedly effective as an antioxidant. &lt;strong&gt;Objectives: &lt;/strong&gt;This study was aimed to examine the antidiabetic effectiveness of ethanol extract of longjack leaf in diabetes mellitus rats. &lt;strong&gt;Methods:&lt;/strong&gt; This study used the total of 24 male white rats which were grouped into four. The normal and the negative control groups were administrated with CMC-Na 0.5% dose 2 ml/200 g body weight; one group was administrated with ethanol extract of longjack leaf dose 176.4 mg/200 g body weight; and the positive control group was administrated with glibenclamide dose 0.09 mg/200 g body weight. Before the extract administration, all of the experimental animals were prior induced into diabetic condition with streptozotocin-nicotinamide. &lt;strong&gt;Results:&lt;/strong&gt; The levels of blood glucose and malondialdehyde in rats after the 14-day extract treatments were 78.73 mg/dl and 1.13 nmol/ml, respectively in the normal control group; 285.84 mg/dl and 10.03 nmol/ml were in the negative control group; 156.77 mg/dl and 3.86 nmol/ml in the group with the administration of ethanol extract of longjack leaf; and 148.63 mg/dl dan 3.64 nmol/ml in the group of glibenclamide administration (p&amp;lt;0.05). The reduction of blood glucose and malondialdehyde levels in the groups of ethanol extract administration of longjack leaf dose 176.4 mg/200 g body weight was similar to the glibenclamide administration dose 0.09 mg/200 g body weight. &lt;strong&gt;Conclusion:&lt;/strong&gt; The ethanol extract of longjack leaf was effective as an antidiabetic.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1582</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ruqiah Ganda Putri Panjaitan&lt;sup&gt;*&lt;/sup&gt;, Agus Astuti&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department of Biology Education, Faculty of Teacher Training and Education, Tanjungpura University. Jl. Prof. Dr. H. Hadari Nawawi, Bansir Laut, Kec. Pontianak Tenggara, Kota Pontianak, West Kalimantan 78124, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Siti Thomas Zulaikhah</style></author><author><style face="normal" font="default" size="100%">Joko Wahyuwibowo</style></author><author><style face="normal" font="default" size="100%">Mochammad Navi Suharto</style></author><author><style face="normal" font="default" size="100%">Bagus Haruno Enggartiasto</style></author><author><style face="normal" font="default" size="100%">Mohammad Iqbal Raka Ortanto</style></author><author><style face="normal" font="default" size="100%">Arrizki Azka Pratama</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Tender Coconut Water (TCW) on TNF-α, IL-1 and IL-6 in Streptozotocin (STZ) and Nicotinamid (NA) Induced Diabetic Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">IL-1</style></keyword><keyword><style  face="normal" font="default" size="100%">IL-6</style></keyword><keyword><style  face="normal" font="default" size="100%">Tender coconut water</style></keyword><keyword><style  face="normal" font="default" size="100%">TNF-α</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">500-505</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Diabetes Mellitus (DM) is characterized by an increase in blood sugar levels also known as hyperglycemia. Continuous hyperglycemia can increase the production of Reactive Oxygen Species (ROS). ROS causes oxidative stress and increases the formation of TNF-α expression as a marker of inflammation. Tender coconut water is rich in sources of free amino acids, L-arginine and vitamin C which can prevent oxidative stress. &lt;strong&gt;Aim and Objectives:&lt;/strong&gt; This research to investigate the effect of tender coconut water on TNF-α, IL-1 and IL-6 in Streptozotocin (STZ) and Nicotinamid (NA) induced diabetic rats. &lt;strong&gt;Material and Methods: &lt;/strong&gt;Experimental research design using posttest control group design. Twenty four male wistar strain rats were used in this study were divided randomly into 4 groups, which are group K1 (control); K2 (DM type 2); K3 (DM type 2+ Glibenclamid 0,18mg/200grBW); K4 (DM type 2+ tender coconut water 8mL/200gr BW). Type 2 Diabetes Mellitus were induced using Streptozotocin (STZ) 65mg/kg body weight and Nicotinamid 230 mg/kg body weight. The administration of tender coconut water were given on day 3 after DM condition is reached, given daily for 4 weeks with dose of 8 mL/200 gr BW. Data on of TNF-α , IL-1 and IL-6 levels were analyzed by One Way Anova. &lt;strong&gt;Result: &lt;/strong&gt;Average TNF-α level, IL-1 level and IL-6 level in Group 2 increased compared to Group 1 , in Group 3 it decreased compared to Group 2 as well as in Group 4 .The results of the analysis has the p values &amp;lt;0.05. &lt;strong&gt;Conclusion:&lt;/strong&gt; Administration of tender coconut water can be decreasing of TNF-α, IL-1 and IL-6 levels in wistar strain male rats with type 2 Diabetes Mellitus.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">500</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Siti Thomas Zulaikhah&lt;sup&gt;1,&lt;/sup&gt;*, Joko Wahyuwibowo&lt;sup&gt;1&lt;/sup&gt;, Mochammad Navi Suharto&lt;sup&gt;2&lt;/sup&gt;, Bagus Haruno Enggartiasto&lt;sup&gt;2&lt;/sup&gt;, Mohammad Iqbal Raka Ortanto&lt;sup&gt;2&lt;/sup&gt;, Arrizki Azka Pratama&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Public Health, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Central Java 50112, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Student Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Central Java 50112, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Student Program Master of Biomedical Science Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Central Java 50112, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wan Nor Iffah Husna Wan Mustaffa</style></author><author><style face="normal" font="default" size="100%">Wan Hafizah W. Jusof</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A Review on Antioxidant and Antidiabetic Activities of Nephelium Lappaceum L.</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antidiabetic</style></keyword><keyword><style  face="normal" font="default" size="100%">Antioxidant</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Nephelium lappaceum L.</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytoconstituents</style></keyword><keyword><style  face="normal" font="default" size="100%">Rambutan</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">July 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1053-1057</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Diabetes mellitus is a chronic disease that occurs in the majority of people worldwide. The number of cases in many countries has been increasing year by year. In Malaysia, the statistics show that the number of diabetic case in 2019 was 3.6 million and expected to increase in 2025 by 7 million. This disease can develop as a result of oxidative stress production in the body. &lt;em&gt;Nephelium lappaceum &lt;/em&gt;was claimed traditionally being used to treat diabetes mellitus. This research is conducted to review the available literature regarding the antioxidant and antidiabetic activities of &lt;em&gt;Nephelium lappaceum&lt;/em&gt; extracts and constituent that contributes to this activity. &lt;strong&gt;Methods:&lt;/strong&gt; The studies included in this review have been selected using several databases including Google Scholar, Wiley Online Library, Science Direct and Pubmed. The keywords used in database search were “&lt;em&gt;Nephelium lappaceum&lt;/em&gt;”, “antioxidant” and “antidiabetic” and covered the period from 2007 onwards. &lt;strong&gt;Results:&lt;/strong&gt; This review revealed that &lt;em&gt;Nephelium lappaceum&lt;/em&gt; extracts have good antioxidant and antidiabetic activities when tested using various methods. These activities are due to the presence of several phytoconstituents in the extract. &lt;strong&gt;Conclusions:&lt;/strong&gt; In conclusion, &lt;em&gt;Nephelium lappaceum &lt;/em&gt;possess antioxidant and antidiabetic activities. It has the potential to be developed as an antidiabetic and antioxidant agent which can be used to treat various oxidative stress-related diseases, including diabetes mellitus.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">1053</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Wan Nor Iffah Husna Wan Mustaffa, Wan Hafizah W. Jusof*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh, MALAYSIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">M Vani</style></author><author><style face="normal" font="default" size="100%">P Uma Maheswari Devi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Seagrass in the Control of Hyperglycemic and Hyperlipidemic States of Streptozotocin Induced Diabetic Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">FBG</style></keyword><keyword><style  face="normal" font="default" size="100%">Halophila beccarii</style></keyword><keyword><style  face="normal" font="default" size="100%">HbA1c</style></keyword><keyword><style  face="normal" font="default" size="100%">HDL</style></keyword><keyword><style  face="normal" font="default" size="100%">LDL</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1716-1721</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;The present study intended to evaluate the beneficial effects of the seagrass &lt;em&gt;Halophila beccarii,&lt;/em&gt; against induced diabetes mellitus in rat models. &lt;em&gt;Halophila beccarii &lt;/em&gt;is a type of Seagrass abundant in Pulicat Lake of Andhra Pradesh, India. &lt;strong&gt;Objective:&lt;/strong&gt; Evaluating the anti-hyperglycemic and anti-hyperlipidemic properties of seagrass extract in comparison with standards. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;STZ induced diabetic rat models were adopted to analyze the effect of long-term treatment with seagrass extract on blood glucose, HbA1c and serum lipids. &lt;strong&gt;Results:&lt;/strong&gt; The methanolic extract of seagrass demonstrated a significant drop of blood glucose levels (52%), in diabetic rats, after 6 h of supplementation. After 40 days of treatment with 500 mg/day of seagrass extract, STZ diabetic rats exhibited tremendous decrease in fasting blood glucose with significant improvement in glycemic control as evidenced by controlled levels of HbA1c. Lower levels of triglycerides, total cholesterol, LDL and VLDL cholesterols and higher levels of HDL cholesterol in STZ-induced diabetic rats provided an evidence for significant anti hyperlipidemic property of seagrass extract. &lt;strong&gt;Conclusion: &lt;/strong&gt;Phytochemicals of seagrass like phenols, flavonoids and bioactive lipids contribute to the anti-hyperglycemic and anti-hyperlipidemic activities and &lt;em&gt;Halophila beccarii &lt;/em&gt;extract serves as a natural supplement in the management of diabetes.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1716</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;M Vani, P Uma Maheswari Devi* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department of Applied Microbiology &amp;amp; Biochemistry, Sri Padmavati Mahila Visvavidyalayam, Tirupati, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Balasubramanian Prasanna</style></author><author><style face="normal" font="default" size="100%">Arumugam Vijaya Anand</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cinnamon species: In vivo Anti-Oxidant Activity of Ethanolic Extracts of Cinnamon Zeylanicum and Cinnamon Cassicae Barks</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-oxidant activity</style></keyword><keyword><style  face="normal" font="default" size="100%">Cinnamon cassicae</style></keyword><keyword><style  face="normal" font="default" size="100%">Cinnamon zeylanicum</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Streptozotocin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">245-247</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; The diabetic population is increasing highly in the worldwide due to the poor control of diabetes and environmental conditions. It disturbs the carbohydrate, protein and lipid metabolism. The natural medicines obtained from the plant source may be the effective treatment of diabetes. &lt;strong&gt;Objective:&lt;/strong&gt; The aim of the present study is to investigate the antioxidant activities of the ethanolic bark extract of &lt;em&gt;Cinnamon zeylanicum&lt;/em&gt; and&lt;em&gt; Cinnamon cassiacae&lt;/em&gt;. in streptozotocin (STZ) induced oxidative stress in rats. &lt;strong&gt;Methods:&lt;/strong&gt; Oxidative stress is induced with a single dose of STZ 60 mg/kg b.w. and then the animals are treated with a dose of various concentrations of ethanolic bark extract of &lt;em&gt;Cinnamon zeylanicum&lt;/em&gt; and&lt;em&gt; Cinnamon cassiacae&lt;/em&gt; (200 mg/kg b.w, 400 mg/kg b.w, and 600 mg/ kg b.w) for 45 days. After the treatment lipid peroxides (LPO), reduce glutathione (GSH), glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) levels are determined. Glibenclamide is used as a standard drug (3 mg/kg b.w.). &lt;strong&gt;Results:&lt;/strong&gt; The present study exposed that the administration of ethanolic bark extract of&lt;em&gt; Cinnamon zeylanicum &lt;/em&gt;and &lt;em&gt;Cinnamon cassiacae&lt;/em&gt; showed a significant decrease in LPO levels. The treatment also finds that the significant increase in GSH, GPx, SOD and CAT levels in the liver, when compared with diabetic control rats. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results proved that the ethanolic bark extract of &lt;em&gt;Cinnamon zeylanicum&lt;/em&gt; and&lt;em&gt; Cinnamon cassiacae&lt;/em&gt; treated group may effectively regulate the antioxidant status in STZ induced diabetic treated groups.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">245</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Balasubramanian Prasanna&lt;sup&gt;1,&lt;/sup&gt;*, Arumugam Vijaya Anand&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of BioChemistry, Manonmaniam Sundaranar University, Tirunelveli, Tamil Nadu, INDIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore-641 046, Tamil Nadu, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Prashanth kumar Goudappala</style></author><author><style face="normal" font="default" size="100%">Ethirajan Sukumar</style></author><author><style face="normal" font="default" size="100%">C V Yogaraje-Gowda</style></author><author><style face="normal" font="default" size="100%">Kashinath RT</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Diallyl Disulphide (DADS) on Gluconeogenesis: A Study in Isolated Alloxan Induced Diabetic Liver</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alloxan</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Diallyldisulphide</style></keyword><keyword><style  face="normal" font="default" size="100%">Gluconeogenesis</style></keyword><keyword><style  face="normal" font="default" size="100%">Glucose-6-phosphatase</style></keyword><keyword><style  face="normal" font="default" size="100%">Total amino acid</style></keyword><keyword><style  face="normal" font="default" size="100%">Total keto acid</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">July 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">777-781</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Coordinated regulation between cellular glucose uptake and endogenous glucose production is indispensable for maintenance of constant blood glucose concentrations. Liver contributes significantly by altering levels of hepatic glucose release, through controlling gluconeogenesis. &lt;strong&gt;Objective: &lt;/strong&gt;To assess effect of Diallyldisulphide on hepatic gluconeogenesis by assessing gluconeogenic substrates and activity of regulatory enzyme glucose-6-phosphatase and to compare the Diallyldisulphide effect on gluconeogenesis with Metformin. &lt;strong&gt;Methodology:&lt;/strong&gt; Wistar albino rats were categorized into four groups; group Inormal control. Group II, III and IV rats were administered single intraperitoneal injection of alloxan monohydrate 150 mg/kg body weight. Rats were maintained on rat diet and water adlibitum for 30 days. On 31&lt;sup&gt;st&lt;/sup&gt; day rats were sacrificed and procured liver tissues. Each liver tissue cut into small slices and group-III and group-IV liver tissues were separately incubated with Diallyldisulphide 4 mg/g liver tissues and Metformin 4 mg/g liver tissues for 60 minutes at 37&lt;sup&gt;&lt;span style=&quot;font-size:10.8333px&quot;&gt;o&lt;/span&gt;&lt;/sup&gt;C. The total amino acids and total keto acids levels were estimated after exposure. And post exposure effect on activity of glucose -6-phoshatase and transaminases were also estimated. &lt;strong&gt;Results: &lt;/strong&gt;Alloxan induced diabetes resulted significant raise in total amino acids, total ketoacids, glucose -6-phosphatase and transaminases activities. Whereas incubation of liver tissues with diallyldisulphide significantly reduced total amino acids, total ketoacids, glucose-6-phosphatase, transaminases activities and ratio of total amino acids and ketoacids as compared to diabetic control rat liver tissues. &lt;strong&gt;Conclusion: &lt;/strong&gt;Study suggested that diallyldisulphide suppressed gluconeogenesis as liver glucose-6-phosphatase activity is significantly decreased and precursors for gluconeogenesis were significantly reduced. Suggesting Diallyldisulphide has role in gluconeogenesis and can hold potentials for glucose homeostasis.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">777</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Prashanth kumar Goudappala&lt;sup&gt;1,2&lt;/sup&gt;, Ethirajan Sukumar&lt;sup&gt;1&lt;/sup&gt;, C V Yogaraje- Gowda&lt;sup&gt;3&lt;/sup&gt;, Kashinath RT&lt;sup&gt;4,&lt;/sup&gt;* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Research and Development, Saveetha Institute of Medical and Technical Science (Deemed University), Thandalam, Chennai-602 105, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biochemistry, Subbaiah Institute of Medical Sciences, Purle, Shivamogga-577 222, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Biochemistry, Bangalore Medical College, Bangalore, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Research and Development, Subbaiah Institute of Medical Sciences, Purle, Shivamogga-577 222, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dharma S</style></author><author><style face="normal" font="default" size="100%">Rahmawati Y</style></author><author><style face="normal" font="default" size="100%">Nessa</style></author><author><style face="normal" font="default" size="100%">Dillasamolla S</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Fibroblast Growth Factor Combination with Ethanol Extract of Morinda citrifolia L. on Blood Glucose Levels</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">FGF</style></keyword><keyword><style  face="normal" font="default" size="100%">Morinda citrifolia</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1558-1562</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;A research has been conducted on the effect of giving Fibroblast Growth Factor (FGF) with &lt;em&gt;Morinda citrifolia&lt;/em&gt; L. ethanol extract. This study aims to determine whether the administration of a combination of FGF with ethanol extract of noni fruit can reduce blood glucose levels in diabetes mice induced by alloxan. FGF requires amino acids in regenerating pancreatic &lt;em&gt;β&lt;/em&gt; cells, where the amino acids expected from noni fruit can provide a signal response in regenerating pancreatic &lt;em&gt;β&lt;/em&gt; cells. In addition, the active substances contained in noni fruit namely xeronine and flavonoid alkaloids can function to reduce blood glucose levels. Test animals were divided into 6 groups, each group consisted of 10 male white mice. Group 1 is a normal control group is a group without any given. Group 2 was a negative control group given 150 mg/kg alloxan. Group 3, 4, and 5 are the treatment groups that are given alloxan and the combination of noni fruit ethanol extract with 3 variations of dose (125; 350; and 1000) mg / KgBW plus FGF dose of 800 mg / kgBW, group 6 is the comparison which is only given FGF alone at a dose of 800 mg / kgBW. The study was conducted for 21 days, observed every 7&lt;sup&gt;th&lt;/sup&gt;, 14&lt;sup&gt;th&lt;/sup&gt;, 21&lt;sup&gt;st &lt;/sup&gt;day using the Easy Touch&lt;sup&gt;®&amp;nbsp;&lt;/sup&gt;GCU digital device. The results of this study showed that administration of noni fruit ethanol extract with FGF was able to reduce blood glucose levels by significance (&lt;em&gt;p &lt;/em&gt;&amp;lt;0.05) and based on the percentage calculation of blood glucose levels as much as 44.9% at a dose of 1000 mg / kgBW on the day observations 21&lt;sup&gt;st&lt;/sup&gt;.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1558</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Dharma S&lt;sup&gt;1,&lt;/sup&gt;*, Rahmawati Y&lt;sup&gt;2&lt;/sup&gt;, Nessa&lt;sup&gt;2&lt;/sup&gt;, Dillasamolla S&lt;sup&gt;1&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy, Andalas University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Indonesian Pioneer Pharmacy College, Padang, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dwitiyanti</style></author><author><style face="normal" font="default" size="100%">Yahdiana Harahap</style></author><author><style face="normal" font="default" size="100%">Berna Elya</style></author><author><style face="normal" font="default" size="100%">Anton Bahtiar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Study of Molecular Docking of Vitexin in Binahong (Anredera cordifolia (Ten.) Steenis) Leaves Extract on Glibenclamide-CYP3A4 Interaction</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Glibenclamide</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitexin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1471-1476</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Diabetes Mellitus is a disease that has a high prevalence in Indonesia. About 90-95% of all diabetes cases were caused by the failure or incapability of insulin target cells to respond to the insulin in normal state. The use of glibenclamide antidiabetic drugs with herbs has been occurred frequently in the community. Vitexin, one of active compounds in binahong (&lt;em&gt;Anredera cordifolia&lt;/em&gt; (Ten.) Steenis) leaves, has been known to have an antidiabetic effects. This study aimed to determine the molecular docking interaction of glibenclamide and vitexin in binahong leaves against CYP3A4 as antidiabetic drug. &lt;strong&gt;Method: &lt;/strong&gt;Molecular docking methods were carried out using Autodock Vina software and interaction was visualized using discovery studio. &lt;strong&gt;Results: &lt;/strong&gt;The study indicated that the value of glibenclamide complex free energy with CYP3A4 was -3.2 kcal/mol and the stability has increasing to -4.4 kcal/mol after docked with vitexin. The glibenclamide and vitexin complexes had 7 Pi alkyl hydrophobic bonds, 1 hydrocarbon hydrogen bond 1 Pi-cation electrostatic interactions, other interactions between Pi bond and sulfur atoms in cysteine amino acid residues, Pi bond interactions in phenylalamin aromatic groups with electron pairs oxygen atom. &lt;strong&gt;Conclusion: &lt;/strong&gt;This study concluded that vitexin could improve glibenclamide stability.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1471</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Dwitiyanti&lt;sup&gt;1&lt;/sup&gt;, Yahdiana Harahap&lt;sup&gt;2&lt;/sup&gt;, Berna Elya&lt;sup&gt;3&lt;/sup&gt;, Anton Bahtiar&lt;sup&gt;4,&lt;/sup&gt;*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Graduated Program of faculty of Pharmacy, Universitas Indonesia, Kampus UI Depok, West Java 16424, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Bioanalysis, Faculty of Pharmacy, Universitas Indonesia, Kampus UI Depok, West Java 16424, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Phytochemistry, Faculty of Pharmacy, Universitas Indonesia, Kampus UI Depok, West Java 16424, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Pharmacology and Toxicology, Faculty of Pharmacy, Universitas Indonesia, Kampus UI Depok, West Java 16424, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amira Kamalrudin</style></author><author><style face="normal" font="default" size="100%">Malina Jasamai</style></author><author><style face="normal" font="default" size="100%">Mahanem Mat Noor</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Ameliorative Effect of Moringa oleifera Fruit Extract on Reproductive Parameters in Diabetic-induced Male Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Fasting blood glucose level</style></keyword><keyword><style  face="normal" font="default" size="100%">Male reproductive</style></keyword><keyword><style  face="normal" font="default" size="100%">Moringa oleifera fruit</style></keyword><keyword><style  face="normal" font="default" size="100%">Sperm quality</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">s54-s58</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Diabetes mellitus negatively impact the male reproductive parameters. The ability of &lt;em&gt;Moringa oleifera&lt;/em&gt; fruit to improve the reproductive parameters in diabetic-induced male has yet to be documented. Aim: To investigate the anti-hyperglycaemic potential of &lt;em&gt;M. oleifera&lt;/em&gt; fruit aqueous extract and its effect on reproductive parameters in diabetic-induced male rats. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; A total of 20 male Sprague Dawley rats were divided into four groups; normal control (without diabetic induction), negative control (diabetes without treatment), positive control (diabetes with metformin) and treatment group (diabetes with 500 mg/kg &lt;em&gt;M. oleifera&lt;/em&gt; fruit aqueous extract). Treatments were given&lt;em&gt; via&lt;/em&gt; oral gavage for 21 consecutive days. Analysis of fasting blood glucose level, sperm quality, testicular histology and relative testis weight were performed. &lt;strong&gt;Results:&lt;/strong&gt; The administration of &lt;em&gt;M. oleifera&lt;/em&gt; fruit aqueous extract exhibited a significant reduction in fasting blood glucose level and a pronounced increase in sperm quality (sperm count, motility, viability and morphology) compared with the negative control group. &lt;em&gt;M. oleifera&lt;/em&gt; fruit extract restored the histology of the testes as they were seen to be packed with sperms and showed an organised spermatogenesis. The relative testis weight showed no significant difference between all groups. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results obtained suggested that &lt;em&gt;M. oleifera&lt;/em&gt; fruit aqueous extract possessed an antihyperglycaemic property and improved the reproductive parameters in diabetic-induced rats&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">s54</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Amira&lt;/strong&gt;&lt;strong&gt; Kamalrudin&lt;sup&gt;1&lt;/sup&gt;, Malina Jasamai&lt;sup&gt;2&lt;/sup&gt;, Mahanem Mat Noor&lt;sup&gt;1* &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, MALAYSIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt; 2&lt;/sup&gt;Drug and Herbal Research Centre, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, MALAYSIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Agung Widiyanto</style></author><author><style face="normal" font="default" size="100%">Effionora Anwar</style></author><author><style face="normal" font="default" size="100%">Tati Nurhayati</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In vitro Assay of Alpha-Glucosidase Inhibitor Activities of Three Seagrasses from Banten Bay, Indonesia</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cymodocea rotundata</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Enhalus acoroides</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemical compound</style></keyword><keyword><style  face="normal" font="default" size="100%">Thalassia hemprichii</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">907-910</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Diabetes mellitus (DM) is an endocrine disorder characterized by high blood glucose levels. One of the approaches for treating DM is by regulating the postprandial blood glucose via inhibition of &amp;alpha;-glucosidase enzymes. Seagrass is known as a plant containing bioactive compounds, especially for therapy antidiabetic. This research aims to evaluate the &amp;alpha;-glucosidase inhibition activity of three species seagrasses (&lt;em&gt;Enhalus acoroides, Thalassia hemprichii&lt;/em&gt; and &lt;em&gt;Cymodocea rotundata&lt;/em&gt;) from the Banten Bay, Indonesia. &lt;strong&gt;Methods:&lt;/strong&gt; The extracts of all parts (root, leaf, and stem) from three seagrasses were prepared with maceration method using 80% ethanol solvents. The &amp;alpha;-glucosidase inhibitory activity was conducted by microplate reader at 400 nm using acarbose as a positive control. Furthermore, the kinetics of &amp;alpha;-glucosidase inhibition, phytochemical screening, and total phenolics content were evaluated against extract which has the most potential &amp;alpha;-glucosidase inhibition. &lt;strong&gt;Results:&lt;/strong&gt; The result showed that the 80% ethanol extracts of &lt;em&gt;Enhalus acoroides&lt;/em&gt; (IC&lt;sub&gt;50&lt;/sub&gt; values 168.15 &amp;plusmn; 2.71 &lt;em&gt;&amp;mu;&lt;/em&gt;g/mL) had the most potential &amp;alpha;-glucosidase inhibitors activity compared with the positive control acarbose, &lt;em&gt;Thalassia hemprichii&lt;/em&gt; and &lt;em&gt;Cymodocea rotundata&lt;/em&gt; (IC&lt;sub&gt;50&lt;/sub&gt; values 197.27 &amp;plusmn; 3.07 &lt;em&gt;&amp;mu;&lt;/em&gt;g/mL, 425.86 &amp;plusmn; 5.15 &lt;em&gt;&amp;mu;&lt;/em&gt;g/mL and 429.28 &amp;plusmn; 8.89 &lt;em&gt;&amp;mu;&lt;/em&gt;g/mL). The kinetic type of inhibition against &amp;alpha;-glucosidase was noncompetitive inhibition. The phytochemical compounds were phenols, flavonoid, terpenes, and tannin with the total phenolic content was 28.76 &amp;plusmn; 2.46 mgGAE/g. &lt;strong&gt;Conclusion:&lt;/strong&gt; &lt;em&gt;Enhalus acoroides&lt;/em&gt; has the strongest inhibitor of &amp;alpha;-glucosidase and can be further developed for DM therapy agents.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">907</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Agung Widiyanto&lt;sup&gt;1&lt;/sup&gt;, Effionora Anwar&lt;sup&gt;1*&lt;/sup&gt;, Tati Nurhayat&lt;sup&gt;i2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Pharmacy, University of Indonesia, Depok 16424, INDONESIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Aquatic Products Technology, Bogor Agricultural University, Bogor 16680, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Karan Rajpurohit Gayathri</style></author><author><style face="normal" font="default" size="100%">Roy Anitha</style></author><author><style face="normal" font="default" size="100%">Thangavelu Lakshmi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Inhibition of Advanced Glycation End-Product Formation by Lutein from Tagetes erecta</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Advance glycation end product</style></keyword><keyword><style  face="normal" font="default" size="100%">Amino-guanidine</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Lutein</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/661</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">734-737</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Advanced glycation end products(AGEs) are formed by non-enzymatic glycation of proteins that enhance vascular permeability in both micro and macro vascular structures by binding to specific macrophage receptors. AGEs affect nearly every type of cells and molecule in the body and play causative role in the vascular complication in diabetes mellitus. &lt;strong&gt;Materials and Method:&lt;/strong&gt; AGE reaction solution was constituted with 10mg/ml bovine serum albumin in 50mM sodium phosphate buffer (pH 7.4) and 0.02% sodium benzoate into 0.2M fructose and 0.2M of glucose. 2.5 ml of the reaction mixture was treated with lutein (10, 20, 40, 60, 60, 80, 100, 120, 140 &amp;mu; g/ml in methanol). Amino guanidine was used as the positive control. After incubating at 37&amp;deg;C for 7 days, the fluorescence intensity of the reaction was determined at excitation and emission wavelength of 350 nm and 450 nm, respectively, using a multimode reader. The percentage activity was calculated with respect to solvent control. &lt;strong&gt;Result:&lt;/strong&gt; 7 days of exposure to lutein showed a maximum inhibition of 89.27&amp;plusmn;0.24 % at 140&amp;mu;g/ml and Amino guanidine exhibited 90% of inhibition. The IC&lt;sub&gt;50&lt;/sub&gt; of Lutein for AGE inhibition was found to be 77.78&amp;mu;g/ml and for AG, 72.66&amp;mu;g/ml.&lt;strong&gt;Conclusion:&lt;/strong&gt; The non-enzymatic adduct formation between the keto group of sugar and amino group of proteins is one of the molecular basis of diabetic complications in hyperglycaemic state. Inhibition of this process will be useful in the management of diabetic complications. Lutein showed dose dependent inhibitory effect on the protein glycation.Hence, it may be used for the management of diabetic complication.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">734</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Karan Rajpurohit Gayathri, Roy Anitha&lt;sup&gt;*&lt;/sup&gt;, Thangavelu Lakshmi &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, 162, Poonamalle High Road, Velapanchavadi, Chennai, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wanwisa Khunawattanakul</style></author><author><style face="normal" font="default" size="100%">Passakorn Boonma</style></author><author><style face="normal" font="default" size="100%">Ronnarit Kampetch</style></author><author><style face="normal" font="default" size="100%">Achida Jaruchotikamol</style></author><author><style face="normal" font="default" size="100%">Benjamart Cushnie</style></author><author><style face="normal" font="default" size="100%">Sakulrat Rattanakiat</style></author><author><style face="normal" font="default" size="100%">Pawitra Pulbutr</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Inhibitory Actions of Lagerstroemia speciosa (L.) Pers. Aqueous and Ethanolic Leaf Extracts against Carbohydrate-digesting Enzymes</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Lagerstroemia speciosa (L.) Pers.</style></keyword><keyword><style  face="normal" font="default" size="100%">α-amylase</style></keyword><keyword><style  face="normal" font="default" size="100%">α-glucosidase</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">s113-s118</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Context:&lt;/strong&gt; The leaves of &lt;em&gt;Lagerstroemia speciosa&lt;/em&gt; (L.) Pers. (banaba) have been consumed traditionally in several Southeast Asian countries for the treatment of diabetes mellitus. The plasma glucose lowering actions of this medicinal plant were proposed to be linked with several mechanisms of action. However, its inhibitory actions against &amp;alpha;-amylase and &amp;alpha;-glucosidase, which play a major role in the regulation of postprandial plasma glucose, have not been clearly established. &lt;strong&gt;Aims:&lt;/strong&gt; This study thus aimed to investigate the effects of &lt;em&gt;Lagerstroemia speciosa&lt;/em&gt; (L.) Pers. aqueous and ethanolic leaf extracts (LSA and LSE extracts, respectively) on in vitro carbohydrate-digesting enzyme activities and enzyme kinetics. Settings and Design: In vitro carbohydrate-digesting enzyme activity assay. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; The activities of &amp;alpha;-amylase and &amp;alpha;-glucosidase were indicated by the amounts of maltose and p-nitrophenol generated in the reactions, respectively.&lt;strong&gt; Statistical analysis used:&lt;/strong&gt; The data were analysed by using one-way ANOVA, followed by Bonferroni post-hoc test. &lt;strong&gt;Results:&lt;/strong&gt; The LSA extract significantly inhibited both &amp;alpha;-amylase and &amp;alpha;-glucosidase enzymes with the IC&lt;sub&gt;50&lt;/sub&gt;s of 1.21&amp;plusmn;0.16 and 49.71&amp;plusmn;0.86 &amp;mu;g/mL, respectively. Meanwhile, the LSE extract selectively inhibited &amp;alpha;-amylase activity (IC&lt;sub&gt;50 &lt;/sub&gt;= 22.21&amp;plusmn;4.00 &amp;mu;g/mL) with no apparent inhibition against &amp;alpha;-glucosidase activity. Both LSA and LSE extracts inhibited &amp;alpha;-amylase enzyme in a mixed inhibition manner whilst the LSA extract also acted as a mixed inhibitor against &amp;alpha;-glucosidase enzyme. The extracts possessed higher binding affinities toward the enzymes, indicated by the lower Ki values, when compared to acarbose (positive control). &lt;strong&gt;Conclusion:&lt;/strong&gt; These results suggest the potential use of the extracts for a control of postprandial plasma glucose.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">s113</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Wanwisa Khunnawattanakul, Passakorn Boonma, Ronnarit Kampetch, Achida Jaruchotikamol, Benjamart Cushnie, Sakulrat Rattanakiat, Pawitra Pulbutr&lt;sup&gt;*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Pharmaceutical Chemistry and Natural Product Research Unit, Faculty of Pharmacy, Mahasarakham University, Maha Sarakham, 44150, THAILAND.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nita Triadisti</style></author><author><style face="normal" font="default" size="100%">Rani Sauriasari</style></author><author><style face="normal" font="default" size="100%">Berna Elya</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Fractionation and α-glucosidase Inhibitory Activity of Fractions from Garcinia hombroniana Pierre Leaves Extracts</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Column chromatography</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Fractionation</style></keyword><keyword><style  face="normal" font="default" size="100%">Thin layer Chromatography</style></keyword><keyword><style  face="normal" font="default" size="100%">α-glucosidase</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May 2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">/files/PJ-9-4/10.5530pj.2017.4.79</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">488-492</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Diabetes mellitus become one of the biggest global health problems of the 21st century. Type 2 diabetes play role for the majority of cases of diabetes worldwide which is characterized by the increase of postprandial blood glucose level. Maintaining postprandial glucose level through inhibition of &amp;alpha;-glucosidase is one of the essential strategies in the treatment of diabetes. Inhibitory effect of &amp;alpha;-glucosidase was commonly used to identify active compounds potentially to treat diabetes. Natural resources have potency as antidiabetic that can be used in diabetes treatment. &lt;strong&gt;Objective:&lt;/strong&gt; The objective of the study is to separate active fraction in the crude extract of &lt;em&gt;Garcinia hombroniana&lt;/em&gt; leaves to facilitate obtaining a pure biologically active compound as the &amp;alpha;-glucosidase inhibitor. &lt;strong&gt;Methods:&lt;/strong&gt; Fractionation to separate active fraction was performed using column and thin layer chromatography methods while &amp;alpha;-glucosidase inhibitory activity assay was performed i&lt;em&gt;n vitro&lt;/em&gt; using spectrophotometric methods at &amp;lambda; 400 nm. &lt;strong&gt;Results:&lt;/strong&gt; Ethyl acetate and methanol extract of &lt;em&gt;G. hombroniana&lt;/em&gt; yielded 14 and 12 fractions, respectively. Two fractions with the higher percent inhibition compared to other factions are fraction 8 from ethyl acetate extract (FEA8) and fraction 3 from methanol extract (FM3). The IC&lt;sub&gt;50&lt;/sub&gt; values of FEA8, FM3 and acarbose are 16.370 &amp;mu;g/mL, 59.042 &amp;mu;g/mL, and 39.534 &amp;mu;g/mL respectively. &lt;strong&gt;Conclusion:&lt;/strong&gt; Fraction 8 from ethyl acetate extract of &lt;em&gt;G. hombroniana&lt;/em&gt; leaves (FEA8) was separated and known in this study as the most bioactive &amp;alpha;-glucosidase inhibitor agent compared with another extract, fractions, and acarbose.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">488</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Nita Triadisti&lt;sup&gt;*&lt;/sup&gt;, Rani Sauriasari, Berna Elya&lt;sup&gt;* &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;em&gt;Faculty of Pharmacy, University of Indonesia, 16424, Depok, INDONESIA.&lt;/em&gt;&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">B. Samuel Thavamani</style></author><author><style face="normal" font="default" size="100%">Vanitha Subburaj</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In vitro Studies on Basella rubra Different Extracts as Inhibitors of Key Enzymes Linked to Diabetes Mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Basella rubra</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes mellitus</style></keyword><keyword><style  face="normal" font="default" size="100%">Postprandial hyperglycemia</style></keyword><keyword><style  face="normal" font="default" size="100%">α-Amylase inhibitory activity</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">107-111</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;Enzyme, inhibiting carbohydrate metabolism and thereby decreasing glucose level is a class of drugs helpful in the management of type 2 Diabetes mellitus. Naturally existing &amp;alpha;-amylase and &amp;alpha;-glucosidase inhibitors from medicinally significant plants are shown to be effective in the management of postprandial hyperglycemia. In this investigation, leaf extract (BRLE), stem extract (BRSE), fruit extract (BRFRE) and flower extract (BRFLE) of &lt;em&gt;Basella rubra &lt;/em&gt;were subjected to evaluate their antioxidant potential and their possible inhibitory effects on &amp;alpha;-amylase and &amp;alpha;-glucosidase. BRLE, BRSE, BRFRE, BRFLE (at concentration 100&amp;mu;g/ml) exhibited 65.78, 56.84, 63.1, 61.03% of &amp;alpha;-amylase inhibitory activity respectively with IC&lt;sub&gt;50&lt;/sub&gt; values of 71.66, 89.69, 73.68, 80.37 &amp;mu;g/ml respectively. In the same way BRLE, BRSE, BRFRE, BRFLE (at concentration 100 &amp;mu;g/ml) exhibited 97.63, 92.79, 82.17, 92.71 % of &amp;alpha;-glucosidase inhibition with an IC&lt;sub&gt;50&lt;/sub&gt; value of 26.97, 28.53, 41.30, 38.80 &amp;mu;g/ml respectively. Among the samples, the leaf extract of &lt;em&gt;B. rubra&lt;/em&gt; registered higher content of total phenolics and flavonoids and also higher antioxidant activity in DPPH, nitric oxide and NBT radical scavenging assays. Though all the parts had shown potent inhibitory effects on &amp;alpha;-amylase and &amp;alpha;-glucosidase, the highest inhibitory potency was observed in the leaf extract of &lt;em&gt;Basella rubra&lt;/em&gt;&amp;nbsp;(p&amp;lt;0.001).&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">107</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;B. Samuel Thavamani&lt;sup&gt;1&lt;/sup&gt;* and Vanitha Subburaj&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacognosy, Sanjo College of Pharmaceutical Studies, Vellapara, Chithali P.O., Kuzhalmannam, Palakkad 678702, Kerala, India.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacognosy, PSG College of Pharmacy, Peelamedu, Coimbatore, Tamilnadu, INDIA.&lt;/p&gt;</style></auth-address></record></records></xml>